GLI1 and neoplasm: The GLI1 expression in tumor tissue of tumor-bearing mice reduced by twofold, when treated with 1 mg/kg bodyweight of rolipram, and by sixfold, when treated with 5 mg/kg bodyweight of rolipram (Figs. 4I, S6).